Member Hub
A central workspace for timely Access360 intelligence, implementation-focused deep dives, member Q&A, China Access Outlook: Strategic Debriefs, and NRDL+ Masterclass materials.
Latest Briefings
China’s C-List and Beyond: Group Insurance, Provider Uptake, and Commercial Payment Strategies
A practical implementation deep-dive with Professor Wanyan on China’s C-List and broader commercial payment landscape — covering group health insurance, provider uptake, cross-stakeholder bottlenecks, orphan therapy coverage, TPAs, and scalable payment strategy.
China’s C-List in Practice: Early Huiminbao Integration Signals
A practical discussion with Professor Wanyan on Huiminbao benefit design changes, regional adoption differences, local negotiation dynamics, and what early implementation may signal for broader commercial insurance integration.
China’s C-List: Behind-the-Scenes Negotiation Dynamics
A practical implementation deep-dive into China’s 2025 C-List negotiation process with Professor Wanyan — covering insurer participation, NHSA’s role, selection criteria, pricing negotiation, and future commercial insurance formulary trends.
China’s 2026 Dual-List Draft Workplan: Earlier Innovation Access, Tighter Lifecycle Pricing Discipline
China’s 2026 NRDL draft workplan signals a more integrated, lifecycle-oriented reimbursement framework: earlier access for innovative therapies, closer regulatory–reimbursement alignment anchored in RWE, and tighter pricing discipline for mature and me-too products.
China’s Healthcare System Is Reorganizing: What It Means for Manufacturers
As China’s healthcare system reorganizes, evolving care pathways and payment dynamics are reshaping how access is secured and how value is realized.
Timely Intelligence and Implementation Deep Dives
Access360 members receive timely interpretive notes as major developments unfold, along with implementation-focused deep dives that provide additional context for understanding China’s evolving health policy, coverage, financing, and adoption environment for medical technologies.
The full Access360 archive is organized by strategic theme for easy navigation.
Access360 Member Q&A
Access360 members may submit questions related to published briefings. Each month, written responses are organized around major themes and shared with members to help clarify policy interpretation, implementation dynamics, and implications for real-world decision-making.
Members may also suggest future briefing topics to help ensure Access360 continues to address issues most relevant to their work and decision needs.
China Access Outlook: Strategic Debrief
Twice each year, NRDL+ produces a flagship executive synthesis examining the major developments shaping China's health policy, pricing, coverage, financing, and adoption environment for medical technologies, with forward-looking implications for life sciences companies.
Both the Mid-Year and Annual China Access Outlook: Strategic Debriefs are available as on-demand executive briefings, either for standalone purchase or through Access360 membership. Access360 members also receive access to an exclusive live member discussion and Q&A following the Annual Strategic Debrief.
Share the China access topics or developments you would like to see covered, and receive a complimentary executive summary when the Mid-Year Strategic Debrief is released in August.
NRDL+ Masterclass
Executive strategic foundation for China access decision-making as China evolves toward a multi-layer coverage environment.
Access pre-read materials, recorded briefings, live case discussions, and question submission forms for NRDL+ Masterclass programs.
Available to registered Masterclass participants.
Named Access360 members are eligible for a 20% Masterclass discount. Group enrollment discounts are available upon request.
Not yet a member?
Access360 membership is available for individual professionals and enterprise teams seeking ongoing China access intelligence.